Clare Ozawa

Insider Reports History

Entity
Individual
Location
One Sansome Street, Suite 3630, San Francisco, CA
Signature
/s/ Brandon Fenn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clare Ozawa:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 Jan 3, 2023 Indirect
Oyster Point Pharma, Inc. Director Stock Option (Right to Buy) 0 Jan 3, 2023 Direct

Insider Reports Filed by Clare Ozawa

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OYST Oyster Point Pharma, Inc. Jan 3, 2023 8 $0 4 Jan 4, 2023 Director
OYST Oyster Point Pharma, Inc. Jun 6, 2022 2 $0 4 Jun 8, 2022 Director
OYST Oyster Point Pharma, Inc. Jan 5, 2022 5 $0 4 Jan 7, 2022 Director, 10%+ Owner
OYST Oyster Point Pharma, Inc. Dec 21, 2021 5 $0 4 Dec 23, 2021 Director, 10%+ Owner
OYST Oyster Point Pharma, Inc. Oct 18, 2021 4 -$8.16M 4 Oct 20, 2021 Director, 10%+ Owner
OYST Oyster Point Pharma, Inc. Jun 7, 2021 2 $0 4 Jun 9, 2021 Director
OYST Oyster Point Pharma, Inc. May 12, 2021 5 $0 4 May 14, 2021 Director, 10%+ Owner